Labadan, Carmelito B.

HRN: 19-88-73  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/17/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/17/2026
03/24/2026
IV
600
Q6
Non Healing Wound
Checking Initial Appropriateness 

 Indication:  EmpiricEmpiric Then Culture-directed    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines